Picture of Galenica AG logo

GALE — Galenica AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Brief: Galenica Raises Its Mid-Term Growth Forecast

Oct 24 (Reuters) - GALENICA AG  GALE.S :
    * IS RAISING ITS MID-TERM GROWTH FORECAST AND NOW EXPECTS
ANNUAL
NET SALES GROWTH OF BETWEEN 3% AND 5%
    * IS CONFIRMING ITS MID-TERM TARGETS FOR RETURN ON SALES
(ROS)1 AT
OVER 9.5% IN THE PRODUCTS & CARE SEGMENT AND UP TO 2% IN
LOGISTICS & IT SEGMENT
    * AIMS TO ACHIEVE THESE TARGETS IN ITS CENTENARY YEAR 2027
WITH AN
EBIT2 OF OVER CHF 250 MILLION
    * EXPECTS A STABLE DEVELOPMENT OF ITS RETURN ON SALES (ROS)1
UP TO
2025
    * ASSUMES THAT THE LEVEL OF INVESTMENTS WILL REMAIN STABLE
OVER
THE NEXT YEARS AND CONTINUES TO AIM FOR NET DEBT2 OF AROUND
+/-2× EBITDA
    * CURRENT GUIDANCE FOR 2023 WITH SALES GROWTH OF BETWEEN 3%
AND 6%
AND EBIT AT ROUGHLY PRIOR YEAR LEVEL (BASED ON THE RESTATED
FIGURES FROM THE PREVIOUS YEAR) REMAINS UNCHANGED

Further company coverage:  GALE.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))

Recent news on Galenica AG

See all news